The global Cancer Genomic Testing market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Centogene AG
LabCorp
Color Genomics
Illumina, Inc.
Gene By Gene Ltd.
23andMe Inc.
Bio-Rad Laboratories
Agilent Technologies
Thermo Fisher Scientific
By Types:
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others
By Applications:
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Cancer Genomic Testing Market Size Analysis from 2023 to 2028
1.5.1 Global Cancer Genomic Testing Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Cancer Genomic Testing Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Cancer Genomic Testing Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Cancer Genomic Testing Industry Impact
Chapter 2 Global Cancer Genomic Testing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Cancer Genomic Testing (Volume and Value) by Type
2.1.1 Global Cancer Genomic Testing Consumption and Market Share by Type (2017-2022)
2.1.2 Global Cancer Genomic Testing Revenue and Market Share by Type (2017-2022)
2.2 Global Cancer Genomic Testing (Volume and Value) by Application
2.2.1 Global Cancer Genomic Testing Consumption and Market Share by Application (2017-2022)
2.2.2 Global Cancer Genomic Testing Revenue and Market Share by Application (2017-2022)
2.3 Global Cancer Genomic Testing (Volume and Value) by Regions
2.3.1 Global Cancer Genomic Testing Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Cancer Genomic Testing Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Cancer Genomic Testing Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Cancer Genomic Testing Consumption by Regions (2017-2022)
4.2 North America Cancer Genomic Testing Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Cancer Genomic Testing Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Cancer Genomic Testing Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Cancer Genomic Testing Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Cancer Genomic Testing Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Cancer Genomic Testing Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Cancer Genomic Testing Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Cancer Genomic Testing Sales, Consumption, Export, Import (2017-2022)
4.10 South America Cancer Genomic Testing Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Cancer Genomic Testing Market Analysis
5.1 North America Cancer Genomic Testing Consumption and Value Analysis
5.1.1 North America Cancer Genomic Testing Market Under COVID-19
5.2 North America Cancer Genomic Testing Consumption Volume by Types
5.3 North America Cancer Genomic Testing Consumption Structure by Application
5.4 North America Cancer Genomic Testing Consumption by Top Countries
5.4.1 United States Cancer Genomic Testing Consumption Volume from 2017 to 2022
5.4.2 Canada Cancer Genomic Testing Consumption Volume from 2017 to 2022
5.4.3 Mexico Cancer Genomic Testing Consumption Volume from 2017 to 2022
Chapter 6 East Asia Cancer Genomic Testing Market Analysis
6.1 East Asia Cancer Genomic Testing Consumption and Value Analysis
6.1.1 East Asia Cancer Genomic Testing Market Under COVID-19
6.2 East Asia Cancer Genomic Testing Consumption Volume by Types
6.3 East Asia Cancer Genomic Testing Consumption Structure by Application
6.4 East Asia Cancer Genomic Testing Consumption by Top Countries
6.4.1 China Cancer Genomic Testing Consumption Volume from 2017 to 2022
6.4.2 Japan Cancer Genomic Testing Consumption Volume from 2017 to 2022
6.4.3 South Korea Cancer Genomic Testing Consumption Volume from 2017 to 2022
Chapter 7 Europe Cancer Genomic Testing Market Analysis
7.1 Europe Cancer Genomic Testing Consumption and Value Analysis
7.1.1 Europe Cancer Genomic Testing Market Under COVID-19
7.2 Europe Cancer Genomic Testing Consumption Volume by Types
7.3 Europe Cancer Genomic Testing Consumption Structure by Application
7.4 Europe Cancer Genomic Testing Consumption by Top Countries
7.4.1 Germany Cancer Genomic Testing Consumption Volume from 2017 to 2022
7.4.2 UK Cancer Genomic Testing Consumption Volume from 2017 to 2022
7.4.3 France Cancer Genomic Testing Consumption Volume from 2017 to 2022
7.4.4 Italy Cancer Genomic Testing Consumption Volume from 2017 to 2022
7.4.5 Russia Cancer Genomic Testing Consumption Volume from 2017 to 2022
7.4.6 Spain Cancer Genomic Testing Consumption Volume from 2017 to 2022
7.4.7 Netherlands Cancer Genomic Testing Consumption Volume from 2017 to 2022
7.4.8 Switzerland Cancer Genomic Testing Consumption Volume from 2017 to 2022
7.4.9 Poland Cancer Genomic Testing Consumption Volume from 2017 to 2022
Chapter 8 South Asia Cancer Genomic Testing Market Analysis
8.1 South Asia Cancer Genomic Testing Consumption and Value Analysis
8.1.1 South Asia Cancer Genomic Testing Market Under COVID-19
8.2 South Asia Cancer Genomic Testing Consumption Volume by Types
8.3 South Asia Cancer Genomic Testing Consumption Structure by Application
8.4 South Asia Cancer Genomic Testing Consumption by Top Countries
8.4.1 India Cancer Genomic Testing Consumption Volume from 2017 to 2022
8.4.2 Pakistan Cancer Genomic Testing Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Cancer Genomic Testing Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Cancer Genomic Testing Market Analysis
9.1 Southeast Asia Cancer Genomic Testing Consumption and Value Analysis
9.1.1 Southeast Asia Cancer Genomic Testing Market Under COVID-19
9.2 Southeast Asia Cancer Genomic Testing Consumption Volume by Types
9.3 Southeast Asia Cancer Genomic Testing Consumption Structure by Application
9.4 Southeast Asia Cancer Genomic Testing Consumption by Top Countries
9.4.1 Indonesia Cancer Genomic Testing Consumption Volume from 2017 to 2022
9.4.2 Thailand Cancer Genomic Testing Consumption Volume from 2017 to 2022
9.4.3 Singapore Cancer Genomic Testing Consumption Volume from 2017 to 2022
9.4.4 Malaysia Cancer Genomic Testing Consumption Volume from 2017 to 2022
9.4.5 Philippines Cancer Genomic Testing Consumption Volume from 2017 to 2022
9.4.6 Vietnam Cancer Genomic Testing Consumption Volume from 2017 to 2022
9.4.7 Myanmar Cancer Genomic Testing Consumption Volume from 2017 to 2022
Chapter 10 Middle East Cancer Genomic Testing Market Analysis
10.1 Middle East Cancer Genomic Testing Consumption and Value Analysis
10.1.1 Middle East Cancer Genomic Testing Market Under COVID-19
10.2 Middle East Cancer Genomic Testing Consumption Volume by Types
10.3 Middle East Cancer Genomic Testing Consumption Structure by Application
10.4 Middle East Cancer Genomic Testing Consumption by Top Countries
10.4.1 Turkey Cancer Genomic Testing Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Cancer Genomic Testing Consumption Volume from 2017 to 2022
10.4.3 Iran Cancer Genomic Testing Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Cancer Genomic Testing Consumption Volume from 2017 to 2022
10.4.5 Israel Cancer Genomic Testing Consumption Volume from 2017 to 2022
10.4.6 Iraq Cancer Genomic Testing Consumption Volume from 2017 to 2022
10.4.7 Qatar Cancer Genomic Testing Consumption Volume from 2017 to 2022
10.4.8 Kuwait Cancer Genomic Testing Consumption Volume from 2017 to 2022
10.4.9 Oman Cancer Genomic Testing Consumption Volume from 2017 to 2022
Chapter 11 Africa Cancer Genomic Testing Market Analysis
11.1 Africa Cancer Genomic Testing Consumption and Value Analysis
11.1.1 Africa Cancer Genomic Testing Market Under COVID-19
11.2 Africa Cancer Genomic Testing Consumption Volume by Types
11.3 Africa Cancer Genomic Testing Consumption Structure by Application
11.4 Africa Cancer Genomic Testing Consumption by Top Countries
11.4.1 Nigeria Cancer Genomic Testing Consumption Volume from 2017 to 2022
11.4.2 South Africa Cancer Genomic Testing Consumption Volume from 2017 to 2022
11.4.3 Egypt Cancer Genomic Testing Consumption Volume from 2017 to 2022
11.4.4 Algeria Cancer Genomic Testing Consumption Volume from 2017 to 2022
11.4.5 Morocco Cancer Genomic Testing Consumption Volume from 2017 to 2022
Chapter 12 Oceania Cancer Genomic Testing Market Analysis
12.1 Oceania Cancer Genomic Testing Consumption and Value Analysis
12.2 Oceania Cancer Genomic Testing Consumption Volume by Types
12.3 Oceania Cancer Genomic Testing Consumption Structure by Application
12.4 Oceania Cancer Genomic Testing Consumption by Top Countries
12.4.1 Australia Cancer Genomic Testing Consumption Volume from 2017 to 2022
12.4.2 New Zealand Cancer Genomic Testing Consumption Volume from 2017 to 2022
Chapter 13 South America Cancer Genomic Testing Market Analysis
13.1 South America Cancer Genomic Testing Consumption and Value Analysis
13.1.1 South America Cancer Genomic Testing Market Under COVID-19
13.2 South America Cancer Genomic Testing Consumption Volume by Types
13.3 South America Cancer Genomic Testing Consumption Structure by Application
13.4 South America Cancer Genomic Testing Consumption Volume by Major Countries
13.4.1 Brazil Cancer Genomic Testing Consumption Volume from 2017 to 2022
13.4.2 Argentina Cancer Genomic Testing Consumption Volume from 2017 to 2022
13.4.3 Columbia Cancer Genomic Testing Consumption Volume from 2017 to 2022
13.4.4 Chile Cancer Genomic Testing Consumption Volume from 2017 to 2022
13.4.5 Venezuela Cancer Genomic Testing Consumption Volume from 2017 to 2022
13.4.6 Peru Cancer Genomic Testing Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Cancer Genomic Testing Consumption Volume from 2017 to 2022
13.4.8 Ecuador Cancer Genomic Testing Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Cancer Genomic Testing Business
14.1 Myriad Genetics
14.1.1 Myriad Genetics Company Profile
14.1.2 Myriad Genetics Cancer Genomic Testing Product Specification
14.1.3 Myriad Genetics Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Positive Bioscience
14.2.1 Positive Bioscience Company Profile
14.2.2 Positive Bioscience Cancer Genomic Testing Product Specification
14.2.3 Positive Bioscience Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Quest Diagnostics
14.3.1 Quest Diagnostics Company Profile
14.3.2 Quest Diagnostics Cancer Genomic Testing Product Specification
14.3.3 Quest Diagnostics Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Centogene AG
14.4.1 Centogene AG Company Profile
14.4.2 Centogene AG Cancer Genomic Testing Product Specification
14.4.3 Centogene AG Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 LabCorp
14.5.1 LabCorp Company Profile
14.5.2 LabCorp Cancer Genomic Testing Product Specification
14.5.3 LabCorp Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Color Genomics
14.6.1 Color Genomics Company Profile
14.6.2 Color Genomics Cancer Genomic Testing Product Specification
14.6.3 Color Genomics Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Illumina, Inc.
14.7.1 Illumina, Inc. Company Profile
14.7.2 Illumina, Inc. Cancer Genomic Testing Product Specification
14.7.3 Illumina, Inc. Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Gene By Gene Ltd.
14.8.1 Gene By Gene Ltd. Company Profile
14.8.2 Gene By Gene Ltd. Cancer Genomic Testing Product Specification
14.8.3 Gene By Gene Ltd. Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 23andMe Inc.
14.9.1 23andMe Inc. Company Profile
14.9.2 23andMe Inc. Cancer Genomic Testing Product Specification
14.9.3 23andMe Inc. Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Bio-Rad Laboratories
14.10.1 Bio-Rad Laboratories Company Profile
14.10.2 Bio-Rad Laboratories Cancer Genomic Testing Product Specification
14.10.3 Bio-Rad Laboratories Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Agilent Technologies
14.11.1 Agilent Technologies Company Profile
14.11.2 Agilent Technologies Cancer Genomic Testing Product Specification
14.11.3 Agilent Technologies Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Thermo Fisher Scientific
14.12.1 Thermo Fisher Scientific Company Profile
14.12.2 Thermo Fisher Scientific Cancer Genomic Testing Product Specification
14.12.3 Thermo Fisher Scientific Cancer Genomic Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Cancer Genomic Testing Market Forecast (2023-2028)
15.1 Global Cancer Genomic Testing Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Cancer Genomic Testing Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Cancer Genomic Testing Value and Growth Rate Forecast (2023-2028)
15.2 Global Cancer Genomic Testing Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Cancer Genomic Testing Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Cancer Genomic Testing Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Cancer Genomic Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Cancer Genomic Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Cancer Genomic Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Cancer Genomic Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Cancer Genomic Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Cancer Genomic Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Cancer Genomic Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Cancer Genomic Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Cancer Genomic Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Cancer Genomic Testing Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Cancer Genomic Testing Consumption Forecast by Type (2023-2028)
15.3.2 Global Cancer Genomic Testing Revenue Forecast by Type (2023-2028)
15.3.3 Global Cancer Genomic Testing Price Forecast by Type (2023-2028)
15.4 Global Cancer Genomic Testing Consumption Volume Forecast by Application (2023-2028)
15.5 Cancer Genomic Testing Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Jul 2024 |
| Category : Services |
Pages : 162 |
Request Sample 
Request Discount 
Inquire Before Buy
